Cancer Family

Mesothelial Neoplasm

Non-malignant108 active trials4 approved drugs13 evidence items

NCIt: C3786
MeSH: D018301

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (49)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 26–49 of 49 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Dose-Response Relationships for Lung Tumor and Pleural Mesothelioma Induction by Repetitive Intratracheal Instillation of a Multiwalled Carbon Nanotube, MWCNT-7, in Rats: Comparison with Inhalation Carcinogenicity Based on Lung Burden.
Ai Maeno, Motoki Hojo, Yoshimitsu Sakamoto et al. · Nanomaterials (Basel) · Aug 20, 2026 · PMID 42646448 · candidate dictionary pubmed
Correction: Song et al. AXL Inactivation Inhibits Mesothelioma Growth and Migration via Regulation of p53 Expression. Cancers 2020, 12, 2757.
Wei Song, Hao Wang, Minmin Lu et al. · Cancers (Basel) · Aug 18, 2026 · PMID 42650037 · candidate dictionary pubmed
Sex-Specific Patterns of Asbestos Exposure and Prognostic Biomarkers in Surgically Treated Pleural Mesothelioma: A Retrospective Cohort Study.
Nicolas Pinzon, Shubham Gulati, Andrew Del Re et al. · Cancers (Basel) · Aug 14, 2026 · PMID 42649937 · candidate dictionary pubmed
Economic Impact of Asbestos in Colombia: Estimation of the Direct and Societal Costs of Lung Cancer and Mesothelioma in 2022.
Guillermo Villamizar, Tim Driscoll, Shane McArdle et al. · Int J Environ Res Public Health · Aug 11, 2026 · PMID 42652359 · candidate dictionary pubmed
Prognostic Factors and Survival in Pericardial Mesothelioma: A Systematic Review and Quantitative Analysis.
Michał Kapałka, Estera Pazek, Michał Krawiec et al. · Cancers (Basel) · Aug 11, 2026 · PMID 42649897 · candidate dictionary pubmed
Radiation-Associated Mesothelioma With Mixed Constrictive-Restrictive Physiology After Mantle-Field Radiotherapy.
Rafik Bensaber, Jacques Serratrice, Nana Kwabena Poku · JACC Case Rep · Aug 11, 2026 · PMID 42578911

· candidate dictionary

pubmed

Experience of the United States-Canadian Mesothelioma Reference Panel 1985-2026: Historical Review and New Developments in Mesothelial Pathology.

Andrew Churg, Richard Attanoos, Mary Beth Beasley et al. · Arch Pathol Lab Med · Aug 10, 2026 · PMID 42603711 · candidate dictionary pubmed

RETRACTED: Schiavello et al. Identification of Redox-Sensitive Transcription Factors as Markers of Malignant Pleural Mesothelioma. Cancers 2021, 13, 1138.

Martina Schiavello, Elena Gazzano, Loredana Bergandi et al. · Cancers (Basel) · Aug 10, 2026 · PMID 42578707 · candidate dictionary pubmed

Modelled effect on mesothelioma mortality of the asbestos ban in Italy and the subsequent phases of exposure.

Alessandro Marinaccio, Claudio Gariazzo, Carolina Mensi et al. · J Epidemiol Community Health · Aug 10, 2026 · PMID 41895818 · candidate dictionary pubmed

Benign multicystic peritoneal mesothelioma presenting as a retroperitoneal pelvic mass in a young woman: a case report.

Enas A Amaireh, Osama Al-Natour, Maen Abdel Nour et al. · J Surg Case Rep · Aug 1, 2026 · PMID 42592572 · candidate dictionary pubmed

Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional Study.

Hiroshi Yokouchi, Hiroshi Nishihara, Yoshiyuki Kenmotsu et al. · Immunotargets Ther · Jan 1, 2026 · PMID 42639079 · candidate dictionary pubmed

Multi-omics integration in malignant pleural mesothelioma: from molecular evolution and immune ecosystems to precision therapy.

Hongmei Li, Kunzhong Zhou, Ruiting Xu et al. · Front Oncol · Jan 1, 2026 · PMID 42676823 · candidate dictionary pubmed

Checkpoint kinase 1 protein as a diagnostic marker for pleural mesothelioma.

Azadeh Asghari Birbaneh, Christos Meristoudis, Caspar Bundgaard Nielsen et al. · J Am Soc Cytopathol · Jan 1, 2026 · PMID 42020260 · candidate dictionary pubmed

Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma.

· World J Surg Oncol · 2010 · PMID 20942962 · validated civic_curation pubmed

MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53.

· Br J Cancer · 2015 · PMID 25668009 · validated civic_curation pubmed

Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial.

· Lancet Respir Med · 2021 · PMID 33515503 · validated civic_curation pubmed

Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial.

· Nat Commun · 2025 · PMID 40691143 · validated civic_curation pubmed

Acquired multiple mutations ALK I1171N, L1196M and G1202R mediate lorlatinib resistance in EML4-ALK-rearranged malignant pleural mesothelioma: a case report.

· Ther Adv Respir Dis · 2020 · PMID 32600123 · validated civic_curation pubmed

Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing.

· PLoS One · 2015 · PMID 25798586 · validated civic_curation pubmed